Figure 6.
VDBP rs7041 SNP and pre-25 hydroxyvitamin D levels predictors of the nivolumab cut-off value of 18.7 μg/mL at 15 days, associated with tumor progression.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.